CN Patent

CN101356170B — Atp-结合弹夹转运蛋白的杂环调控剂

Assigned to Vertex Pharmaceuticals Inc · Expires 2012-09-26 · 14y expired

What this patent protects

本发明的化合物和其药学上可接受的组合物可用作ATP-结合弹夹(“ABC”)转运蛋白或其片段的调控剂，包括囊性纤维化跨膜电导调节剂(“CFTR”)。本发明也涉及使用本发明化合物治疗ABC转运蛋白介导的疾病的方法。

USPTO Abstract

本发明的化合物和其药学上可接受的组合物可用作ATP-结合弹夹(“ABC”)转运蛋白或其片段的调控剂，包括囊性纤维化跨膜电导调节剂(“CFTR”)。本发明也涉及使用本发明化合物治疗ABC转运蛋白介导的疾病的方法。

Drugs covered by this patent

Kalydeco (IVACAFTOR) · Vertex Pharms Inc

Patent Metadata

Patent number: CN101356170B
Jurisdiction: CN
Classification: —
Expires: 2012-09-26
Drug substance claim: No
Drug product claim: No
Assignee: Vertex Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.